| Jeffrey T Layne, MD | |
|
1181 Old Country Rd, Plainview, NY 11803-5018 | |
| (516) 933-6060 | |
| (516) 933-1107 |
| Full Name | Jeffrey T Layne |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 35 Years |
| Location | 1181 Old Country Rd, Plainview, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699724823 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 199206 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integrated Medical Professionals Pllc | 6406868462 | 85 |
News Archive
For those concerned with the troublesome effects of genetic resistance to drugs and pesticides, the conventional wisdom of evolution offers a reassuring word: In the absence of the original chemical threat, most resistance mutations would cause a disadvantage to their hosts and might be expected to quickly leave the genetic landscape once the use of a drug or insecticide is suspended or withdrawn.
The Pulmonary Hypertension Association (PHA) and Actelion Pharmaceuticals US, Inc., today announced Dr. Vallerie McLaughlin of the University of Michigan Health System as the recipient of the annual PHA Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care. As part of the award, the University of Michigan System will receive a grant in the amount of $50,000 to support continued excellence in care for patients with PAH.
A new study led by Marc Veldhoen, principal investigator at Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal) with an interdisciplinary team of clinicians and researchers from Faculdade de Medicina da Universidade de Lisboa (FMUL) and Centro Hospitalar Lisboa Norte (CHLN) and collaborators at Instituto Português do Sangue e Transplantação (IPST), shows that 90% of subjects have detectable antibodies 40 days up to 7 months post contracting COVID-19.
Two new reports issuing in Science Translational Medicine today showcase the potential of teams of scientists working together to solve increasingly complex medical problems.
The Coalition for Pulmonary Fibrosis (CPF) announced today it is joining with the American Thoracic Society (ATS) and lung health organizations around the globe for 2010: The Year of the Lung, a multi-faceted campaign that aims to raise awareness about the importance of lung health, generate social and political support for preventing and treating lung disease and encouraging increased public and private funding for lung disease research and development.
› Verified 2 days ago
| Entity Name | Metropolitan Lithotriptor Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891027967 PECOS PAC ID: 5193615730 Enrollment ID: O20040317001512 |
News Archive
For those concerned with the troublesome effects of genetic resistance to drugs and pesticides, the conventional wisdom of evolution offers a reassuring word: In the absence of the original chemical threat, most resistance mutations would cause a disadvantage to their hosts and might be expected to quickly leave the genetic landscape once the use of a drug or insecticide is suspended or withdrawn.
The Pulmonary Hypertension Association (PHA) and Actelion Pharmaceuticals US, Inc., today announced Dr. Vallerie McLaughlin of the University of Michigan Health System as the recipient of the annual PHA Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care. As part of the award, the University of Michigan System will receive a grant in the amount of $50,000 to support continued excellence in care for patients with PAH.
A new study led by Marc Veldhoen, principal investigator at Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal) with an interdisciplinary team of clinicians and researchers from Faculdade de Medicina da Universidade de Lisboa (FMUL) and Centro Hospitalar Lisboa Norte (CHLN) and collaborators at Instituto Português do Sangue e Transplantação (IPST), shows that 90% of subjects have detectable antibodies 40 days up to 7 months post contracting COVID-19.
Two new reports issuing in Science Translational Medicine today showcase the potential of teams of scientists working together to solve increasingly complex medical problems.
The Coalition for Pulmonary Fibrosis (CPF) announced today it is joining with the American Thoracic Society (ATS) and lung health organizations around the globe for 2010: The Year of the Lung, a multi-faceted campaign that aims to raise awareness about the importance of lung health, generate social and political support for preventing and treating lung disease and encouraging increased public and private funding for lung disease research and development.
› Verified 2 days ago
| Entity Name | Integrated Medical Professionals Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346203536 PECOS PAC ID: 6406868462 Enrollment ID: O20060613000088 |
News Archive
For those concerned with the troublesome effects of genetic resistance to drugs and pesticides, the conventional wisdom of evolution offers a reassuring word: In the absence of the original chemical threat, most resistance mutations would cause a disadvantage to their hosts and might be expected to quickly leave the genetic landscape once the use of a drug or insecticide is suspended or withdrawn.
The Pulmonary Hypertension Association (PHA) and Actelion Pharmaceuticals US, Inc., today announced Dr. Vallerie McLaughlin of the University of Michigan Health System as the recipient of the annual PHA Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care. As part of the award, the University of Michigan System will receive a grant in the amount of $50,000 to support continued excellence in care for patients with PAH.
A new study led by Marc Veldhoen, principal investigator at Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal) with an interdisciplinary team of clinicians and researchers from Faculdade de Medicina da Universidade de Lisboa (FMUL) and Centro Hospitalar Lisboa Norte (CHLN) and collaborators at Instituto Português do Sangue e Transplantação (IPST), shows that 90% of subjects have detectable antibodies 40 days up to 7 months post contracting COVID-19.
Two new reports issuing in Science Translational Medicine today showcase the potential of teams of scientists working together to solve increasingly complex medical problems.
The Coalition for Pulmonary Fibrosis (CPF) announced today it is joining with the American Thoracic Society (ATS) and lung health organizations around the globe for 2010: The Year of the Lung, a multi-faceted campaign that aims to raise awareness about the importance of lung health, generate social and political support for preventing and treating lung disease and encouraging increased public and private funding for lung disease research and development.
› Verified 2 days ago
| Entity Name | Hudson Valley Lithotripsy Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437242781 PECOS PAC ID: 4183078603 Enrollment ID: O20231002001672 |
News Archive
For those concerned with the troublesome effects of genetic resistance to drugs and pesticides, the conventional wisdom of evolution offers a reassuring word: In the absence of the original chemical threat, most resistance mutations would cause a disadvantage to their hosts and might be expected to quickly leave the genetic landscape once the use of a drug or insecticide is suspended or withdrawn.
The Pulmonary Hypertension Association (PHA) and Actelion Pharmaceuticals US, Inc., today announced Dr. Vallerie McLaughlin of the University of Michigan Health System as the recipient of the annual PHA Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care. As part of the award, the University of Michigan System will receive a grant in the amount of $50,000 to support continued excellence in care for patients with PAH.
A new study led by Marc Veldhoen, principal investigator at Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal) with an interdisciplinary team of clinicians and researchers from Faculdade de Medicina da Universidade de Lisboa (FMUL) and Centro Hospitalar Lisboa Norte (CHLN) and collaborators at Instituto Português do Sangue e Transplantação (IPST), shows that 90% of subjects have detectable antibodies 40 days up to 7 months post contracting COVID-19.
Two new reports issuing in Science Translational Medicine today showcase the potential of teams of scientists working together to solve increasingly complex medical problems.
The Coalition for Pulmonary Fibrosis (CPF) announced today it is joining with the American Thoracic Society (ATS) and lung health organizations around the globe for 2010: The Year of the Lung, a multi-faceted campaign that aims to raise awareness about the importance of lung health, generate social and political support for preventing and treating lung disease and encouraging increased public and private funding for lung disease research and development.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey T Layne, MD 1181 Old Country Rd, Plainview, NY 11803-5018 Ph: (516) 933-6060 | Jeffrey T Layne, MD 1181 Old Country Rd, Plainview, NY 11803-5018 Ph: (516) 933-6060 |
News Archive
For those concerned with the troublesome effects of genetic resistance to drugs and pesticides, the conventional wisdom of evolution offers a reassuring word: In the absence of the original chemical threat, most resistance mutations would cause a disadvantage to their hosts and might be expected to quickly leave the genetic landscape once the use of a drug or insecticide is suspended or withdrawn.
The Pulmonary Hypertension Association (PHA) and Actelion Pharmaceuticals US, Inc., today announced Dr. Vallerie McLaughlin of the University of Michigan Health System as the recipient of the annual PHA Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care. As part of the award, the University of Michigan System will receive a grant in the amount of $50,000 to support continued excellence in care for patients with PAH.
A new study led by Marc Veldhoen, principal investigator at Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal) with an interdisciplinary team of clinicians and researchers from Faculdade de Medicina da Universidade de Lisboa (FMUL) and Centro Hospitalar Lisboa Norte (CHLN) and collaborators at Instituto Português do Sangue e Transplantação (IPST), shows that 90% of subjects have detectable antibodies 40 days up to 7 months post contracting COVID-19.
Two new reports issuing in Science Translational Medicine today showcase the potential of teams of scientists working together to solve increasingly complex medical problems.
The Coalition for Pulmonary Fibrosis (CPF) announced today it is joining with the American Thoracic Society (ATS) and lung health organizations around the globe for 2010: The Year of the Lung, a multi-faceted campaign that aims to raise awareness about the importance of lung health, generate social and political support for preventing and treating lung disease and encouraging increased public and private funding for lung disease research and development.
› Verified 2 days ago
Dr. Jeffrey Haberman, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 875 Old Country Rd, Suite 301, Plainview, NY 11803 Phone: 516-931-1710 Fax: 516-931-2362 | |
Dr. Tso-jen Hsiao, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 100 Manetto Hill Rd, Suite 209, Plainview, NY 11803 Phone: 516-938-4550 Fax: 516-938-4559 | |
Robert Kevin Luntz, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 875 Old Country Rd, Ste 301, Plainview, NY 11803 Phone: 516-931-1710 Fax: 516-931-2362 | |
Robert M Steinberger, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1181 Old Country Rd, Plainview, NY 11803 Phone: 516-933-6060 Fax: 516-933-1107 | |
Dr. Elliott Lieberman, M.D. Urology Medicare: Medicare Enrolled Practice Location: 875 Old Country Rd, Ste 301, Plainview, NY 11803 Phone: 516-931-1710 Fax: 516-931-2362 | |
Theodore P Felderman, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 700 Old Country Rd, Plainview, NY 11803 Phone: 516-433-0262 Fax: 516-433-0466 |